Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BDE vs Exparel in Hernia Patients Undergoing Abdominal Wall Reconstruction
NCT07518238Phase 2Enrolling by invitation
- Sponsor
- Baylor Scott & White Research Institute
- Start
- Jan 2026
- Primary completion
- Nov 2029
- Modality
- Recombinant Proteins and Enzymes, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of bupivacaine, dexamethasone, epinephrine in postoperative pain, sponsored by Baylor Scott & White Research Institute. Started Jan 2026; status: enrolling by invitation.
02
Drugs
bupivacainedexamethasoneepinephrine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT07518238.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07518238.